Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant improvement in their symptoms after a year on the drug, researchers reported March 6 in The New England ...

More patients receiving obinutuzumab vs placebo had primary end point of SLE Responder Index 4. HealthDay News — For patients with systemic lupus erythematosus (SLE), obinutuzumab, a glycoengineered ...

The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.

Article was co-written by Danielle Brown and Sandy Buechler. Living with Lupus brings unique challenges, particularly regarding dental health, which often requires special attention. Dental treatments ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. She specializes in ...

Patients with lupus nephritis complicated by thrombotic microangiopathy tend to have high death risk and poor renal outcomes. They need vital and effective therapies.

Obesity is independently associated with worse patient-reported outcomes in women with systemic lupus erythematosus, including disease activity, depressive symptoms, pain and fatigue, according to new ...

Investigators assessed shear wave elastography (SWE) in detecting subclinical renal damage in patients with LN currently in clinical remission.

As Kenya joins the world in creating awareness of lupus disease, experts have called on individuals with the disease to adhere to medication to prevent organ failure. Dr Fred Otieno, a rheumatologist ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. WASHINGTON — Patients with lupus and type 2 diabetes who ...